Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 4
2005 9
2006 7
2007 5
2008 3
2009 8
2010 5
2011 9
2012 3
2013 8
2014 4
2015 2
2016 7
2017 7
2018 2
2019 3
2020 5
2021 3
2022 5
2023 1
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ryoichi noguchi (2 results)?
Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular Carcinoma.
Tsuji Y, Namisaki T, Takaya H, Nishimura N, Noguchi R, Asada S, Shibamoto A, Kubo T, Iwai S, Tomooka F, Koizumi A, Matsuda T, Tanaka M, Yorioka N, Inoue T, Fujinaga Y, Nishimura N, Kitagawa K, Sato S, Kaji K, Asada K, Mitoro A, Yoshiji H. Tsuji Y, et al. Among authors: noguchi r. Dig Dis Sci. 2025 Jun;70(6):2156-2166. doi: 10.1007/s10620-025-08884-5. Epub 2025 Mar 12. Dig Dis Sci. 2025. PMID: 40072765
Fibrosis stage is an independent predictor of liver-related complications in primary biliary cholangitis.
Fujinaga Y, Namisaki T, Tsuji Y, Shibamoto A, Kubo T, Koizumi A, Matsuda T, Inoue T, Iwai S, Tomooka F, Tanaka M, Takaya H, Noguchi R, Nishimura N, Sato S, Kitagawa K, Kaji K, Akahane T, Mitoro A, Asada K, Yoshiji H. Fujinaga Y, et al. Among authors: noguchi r. Hepatol Res. 2025 Jul;55(7):968-976. doi: 10.1111/hepr.14192. Epub 2025 Apr 7. Hepatol Res. 2025. PMID: 40317568
Clinical Significance of Marginal Zinc Deficiency as a Predictor of Covert Hepatic Encephalopathy in Patients with Liver Cirrhosis.
Matsuda T, Namisaki T, Shibamoto A, Asada S, Tomooka F, Kubo T, Koizumi A, Tanaka M, Iwai S, Inoue T, Tsuji Y, Fujinaga Y, Nishimura N, Sato S, Kitagawa K, Kaji K, Mitoro A, Asada K, Takaya H, Noguchi R, Akahane T, Yoshiji H. Matsuda T, et al. Among authors: noguchi r. Int J Mol Sci. 2025 Apr 28;26(9):4184. doi: 10.3390/ijms26094184. Int J Mol Sci. 2025. PMID: 40362419 Free PMC article.
Cecal Tuberculosis Mimicking Submucosal Tumor.
Kawaratani H, Moriya K, Ishida K, Noguchi R, Namisaki T, Takaya H, Douhara A, Yoshiji H, Yamao J, Fujii H, Fukui H. Kawaratani H, et al. Among authors: noguchi r. Intern Med. 2016;55(14):1859-63. doi: 10.2169/internalmedicine.55.5139. Epub 2016 Jul 15. Intern Med. 2016. PMID: 27432093 Free article.
Impact of renin-angiotensin system in hepatocellular carcinoma.
Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Aihara Y, Fukui H. Yoshiji H, et al. Among authors: noguchi r. Curr Cancer Drug Targets. 2011 May;11(4):431-41. doi: 10.2174/156800911795538084. Curr Cancer Drug Targets. 2011. PMID: 21395547 Review.
The effect of inflammatory cytokines in alcoholic liver disease.
Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H. Kawaratani H, et al. Among authors: noguchi r. Mediators Inflamm. 2013;2013:495156. doi: 10.1155/2013/495156. Epub 2013 Dec 9. Mediators Inflamm. 2013. PMID: 24385684 Free PMC article. Review.
Association between Equol Production Status and Nonalcoholic Steatohepatitis.
Akahane T, Kaya D, Noguchi R, Kaji K, Miyakawa H, Fujinaga Y, Tsuji Y, Takaya H, Sawada Y, Furukawa M, Kitagawa K, Ozutsumi T, Kawaratani H, Moriya K, Namisaki T, Yoshiji H. Akahane T, et al. Among authors: noguchi r. Int J Mol Sci. 2021 Nov 2;22(21):11904. doi: 10.3390/ijms222111904. Int J Mol Sci. 2021. PMID: 34769332 Free PMC article.
Predictive parameter of tolvaptan effectiveness in cirrhotic ascites.
Kawaratani H, Fukui H, Moriya K, Noguchi R, Namisaki T, Uejima M, Kitade M, Takeda K, Okura Y, Kaji K, Nishimura N, Takaya H, Aihara Y, Sawada Y, Sato S, Seki K, Mitoro A, Yamao J, Yoshiji H. Kawaratani H, et al. Among authors: noguchi r. Hepatol Res. 2017 Aug;47(9):854-861. doi: 10.1111/hepr.12826. Epub 2016 Nov 9. Hepatol Res. 2017. PMID: 27704665
101 results